Business Context and Reporting Period
Company: Ecolab Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 5, 2008
Event: Entry into a Material Definitive Agreement and creation of a direct financial obligation.
Key Financial Metrics
This filing details a specific debt issuance rather than periodic operating results. Key metrics related to the transaction include:
- Debt Issuance: $250,000,000 aggregate principal amount of 4.875% Notes due 2015.
- Interest Rate: 4.875% per annum.
- Interest Payment Dates: February 15 and August 15, commencing August 15, 2008.
- Maturity Date: February 15, 2015.
- Public Offering Price: 99.805% of principal amount.
- Net Proceeds: Approximately $247.95 million (before expenses).
- Debt Structure: Unsecured and unsubordinated obligations ranking equally with existing unsecured indebtedness.
Material Changes and Use of Proceeds
The Company entered into an underwriting agreement to issue the Notes. The net proceeds are designated for the following purposes:
- Repayment of a portion of commercial paper borrowings.
- Financing a portion of the acquisitions of Microtek Medical Holdings, Inc. and Ecovation, Inc.
- General corporate and working capital purposes.
The filing does not provide comparative operating data (revenue, profit, cash flow) for the period.
Guidance, Risks, and Covenants
Covenants and Restrictions: The Indenture limits the Company's ability to incur certain liens or consolidate, merge, or sell all or substantially all of its assets.
Redemption: The Company may redeem the Notes prior to maturity at redemption prices including a make-whole premium upon 30 days' notice.
Change of Control: In the event of a change of control and a subsequent downgrade of the Notes below investment grade by both Moody's and S&P, the Company must offer to repurchase the Notes at 101% of principal plus accrued interest.
Risks: The filing notes customary event of default provisions. The underwriters (Citigroup, Credit Suisse, JP Morgan) have performed and may continue to perform investment banking and lending services for the Company.
Investor Verification Checklist
- Verify the exact net proceeds received after deducting underwriting fees and expenses.
- Confirm the specific amount of commercial paper being retired with these proceeds.
- Review the Supplemental Indenture (Exhibit 4.2) for detailed covenants regarding liens and asset sales.
- Monitor the Company's credit ratings to assess the risk of triggering the change of control repurchase provision.
- Check subsequent filings for the closing of the Microtek Medical and Ecovation acquisitions.